Tricida Profile



Odds of Distress

Check how we calculate scores
Equity ratings for Tricida are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 22, 2019 and ending today September 20, 2019. Click here to learn more.

Tricida Summary

Tricida (TCDA) is traded on BATS Exchange in USA and employs 90 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.66B. Tricida conducts business under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 49.39M outstanding shares of which 3.44M shares are at this time shorted by private and institutional investors with about 17.69 trading days to cover. The company currently holds about 393.83M in cash with (117.71M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.97.
Check Tricida Probability Of Bankruptcy

Ownership Allocation (%)

Tricida Target Price Odds Analysis

Odds Below 31.98HorizonTargetOdds Above 31.98
47.97%30 days 31.98 51.94%
Based on normal probability distribution, the odds of Tricida to move above current price in 30 days from now is about 51.94% (This Tricida probability density function shows the probability of Tricida Stock to fall within a particular range of prices over 30 days) .

Tricida Top Holders

Tricida Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Orbimed Advisors LlcCommon Shares11.1 M438.6 M
Price T Rowe Associates IncCommon Shares3.9 M153.9 M
View Tricida Diagnostics

Tricida Risk Profiles

Tricida Key Fundamentals

Tricida Against Markets

Tricida Vital Trading Data

Tricida, Inc., a pharmaceutical company, focuses on the development and commercialization of its drug candidate, TRC101, a non-absorbed, orally-administered polymer designed as a potential treatment for metabolic acidosis in patients with chronic kidney disease . Tricida, Inc. was founded in 2013 and is headquartered in South San Francisco, California. Tricida operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 90 people. more
CEOGerrit KlaernerView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address7000 Shoreline Court
ExchangeBATS Exchange
IndustryDrug Manufacturers - Specialty & Generic
Phone415 429 7800
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestAugust 15, 2019

Tricida Corporate Directors

Robert Alpern Independent Director
David Hirsch Independent Director
Sandra Coufal Independent Director
Also please take a look at World Market Map. Please also try Portfolio Reporting module to create custom reports across your portfolios and generate quick suggestion pitch.